Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
28
Feb |
Innovative HeRO(R) Device Improves Outcomes, Quality Of Life For Kidney Disease PatientsCategory: Urology / Nephrology | Leave a Comment |
One thousand end stage renal disease patients have now benefited from a novel device that provides vital access to their blood for filtering and replacement kidney function, and reduces the risk of potentially fatal bacteremia infection. The HeRO® Vascular Access Device, produced by Hemosphere, Inc., in Eden Prairie, Minn., provides access for hemodialysis similar to a conventional graft…
|
28
Feb |
SensAble Adds Impression Scanning And OpenScan™ Interface To The SensAble Dental Lab SystemCategory: Dentistry | Leave a Comment |
SensAble Technologies, Inc®, a leading provider of 3D touch-enabled modeling systems, dental CAD/CAM solutions and haptic devices, has announced that it will be offering a second, fully integrated scanner option for the SensAble Dental Lab System, as well as SensAble’s new OpenScan™ software interface…
|
28
Feb |
Boston Scientific To Participate In RBC Capital Markets Health Care ConferenceCategory: Conferences | Leave a Comment |
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming RBC Capital Markets Health Care Conference in New York City. Ray Elliott, President and Chief Executive Officer, and Sam Leno, Executive Vice President and Chief Operations Officer, will participate in a 30-minute discussion about the Company on Tuesday, March 2, beginning at approximately 8:00 a.m. ET…
|
27
Feb |
Supelco(R) Introduces Breakthrough In Bioseparations Performance — Ascentis(R) Express ES-C18 HPLC ColumnsCategory: Medical Devices / Diagnostics | Leave a Comment |
Supelco, a division of Sigma-Aldrich® (Nasdaq: SIAL), announced the launch of Ascentis Express Peptide ES-C18, a high-speed, high-performance liquid chromatography (HPLC) column based on a new 160 angstrom Fused-Core™ particle design…
|
27
Feb |
BioMedix Vascular Solutions, Inc. Partners With Howard University Hospital To Showcase High-Quality, Cost-effective Collaborative Care ModelCategory: Vascular | Leave a Comment |
BioMedix Vascular Solutions, Inc. announced that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral Arterial Disease (PAD)…
|
27
Feb |
Inclement East Coast Weather Delays ProUroScan(TM) FDA ReviewCategory: Prostate / Prostate Cancer | Leave a Comment |
ProUroCare Medical, Inc. (OCT Bulletin Board: PUMD, PUMDU, PUMDW), a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C…
|
27
Feb |
Pain Relief For Osteoarthritis Provided By Electromagnetic PulsesCategory: Arthritis / Rheumatology | Leave a Comment |
Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers…
|
27
Feb |
New Biomedical Engineering Chair Earns High HonorsCategory: Neurology / Neuroscience | Leave a Comment |
Just weeks into his post as John S. Dunn Distinguished Professor and founding chair of the University of Houston’s new department of biomedical engineering, Metin Akay is already being recognized…
|
26
Feb |
Stentys Self-expanding Stent Receives CE Marking To Treat Acute Coronary Syndrome (ACS)Category: Cardiovascular / Cardiology | Leave a Comment |
Medical device pioneer Stentys announced that it has received CE Marking for its self-expanding and disconnectable stent to treat acute coronary syndrome (ACS)…
|
26
Feb |
Novel Antitoxin Strategy Developed Using “Tagged Binding Agents”Category: Infectious Diseases / Bacteria / Viruses | Leave a Comment |
A study involving the world’s deadliest substance has yielded a new strategy to clear toxins from the body - which may lead to more efficient strategies against toxins that may be used in a bioterrorist event, as well as snake bites, scorpion stings, and even some important chronic diseases…